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ABSTRACT
Nuclear RNA export pathways in eukaryotes are
often linked to the fate of a given RNA. There-
fore, the choice of export pathway should be well-
controlled to avoid an unfavorable effect on gene
expression. Although some RNAs could be ex-
ported by more than one pathway, little is known
about how the choice is regulated. This issue
is highlighted when the human immunodeficiency
virus type 1 (HIV-1) Rev protein induces the export
of singly spliced and unspliced HIV-1 transcripts.
How these RNAs are exported is not well under-
stood because such transcripts should have the
possibility of utilizing CRM1-dependent export via
Rev or cellular TAP/NXF1-dependent export via the
transcription/export (TREX) complex, or both. Here
we found that Rev suppressed TAP/NXF1-dependent
export of model RNA substrates that recapitulated vi-
ral transcripts. In this effect, Rev interacted with the
cap-binding complex and inhibited the recruitment
of the TREX complex. Thus, Rev controls the identity
of the factor occupying the cap-proximal region that
determines the RNA export pathway. This ribonucle-
oprotein remodeling activity of Rev may favor viral
gene expression.
INTRODUCTION
Different classes of RNA in eukaryotic cells are exported
by distinct sets of export factors, that is, by distinct ex-
port pathways (1,2). In bulk mRNA export, a multi-protein
complex, the transcription/export (TREX) complex, is re-
cruited to a region near the 5′-terminal cap structure of
mRNA since the cap-binding complex (CBC) directly in-
teracts with Aly/REF, a component of the TREX complex
(3–5). The complex in turn recruits themajormRNAexport
receptor TAP-p15 heterodimer to mRNAs (TAP and p15
are also called NXF1 andNXT1, respectively) (6–9) mainly
through the interaction between TAP and Aly/REF (10–
12). In addition to the mechanism that recruits TAP to mR-
NAs, the nuclear retention mechanism contributes to the fi-
delity of mRNA export. Intron-containing pre-mRNAs are
retained in the nucleus, as a result of the formation of splic-
ing complexes, until they are completely spliced (13,14).
In some RNA viruses, such as human immunodeficiency
virus type 1 (HIV-1), cellular and viral protein factors
and cis-acting RNA elements serve to overcome the nu-
clear retentionmechanism for intron-containing transcripts
(1,15,16). HIV-1 has two intronic regions in its genome.
HIV-1-infected cells produce three types of viral transcripts,
an unspliced transcript containing both introns (9-kb tran-
script), singly spliced transcripts in which only the first in-
tron has been removed (4-kb transcript), and fully spliced
transcripts (2-kb transcript). The current consensus view
of RNA export regulation by the viral protein Rev is as
follows (Figure 1A): in the early stage of infection, only
the fully spliced transcript is exported to the cytoplasm,
presumably via the TAP-dependent mRNA export path-
way. The fully spliced transcript encodes the Rev protein,
which has a specific activity to bind to the Rev response el-
ement (RRE) located in the second intron. Rev has both
a nuclear localization signal that is recognized by a subset
of importins/karyopherins (17,18) and a leucine-rich nu-
clear export signal (NES) that is recognized by CRM1 (19–
23); therefore, it can shuttle between the nucleus and cyto-
plasm through nuclear pore complexes (NPCs). In the later
stage of infection, the Rev protein, which has accumulated
in the nucleus, binds to RRE and promotes the export of
both singly spliced and unspliced transcripts via the CRM1-
dependent pathway, which leads to the expression of differ-
ent sets of viral protein factors and eventually to propaga-
tion of the virus (1).
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Figure 1. Reconstruction of the export of the singly spliced transcript in Xenopus oocytes. (A) Gene expression of HIV-1 is regulated by RNA export.
(B) Schematic representation of pre-ftzRRE RNA used for the export analysis. (C) 32P-labeled pre-ftzRRE RNA was microinjected into the nucleus of
Xenopus oocytes together with 32P-labeled U1ftz (elongated U1), U6RRE and U6ss, in either the absence (lanes 1–8) or presence (lanes 9–14) of the
purified recombinant Rev protein (160 fmol/oocyte), with either CTE (50 fmol/oocyte; lanes 5, 6, 11 and 12) or the CTE mutant M36, which does not
bind TAP/NXF1 (CTEmut, 50 fmol/oocyte; lanes 7, 8, 13 and 14), or without the inhibitor (lanes 1–4, 9 and 10). RNA was extracted from nuclear (N)
and cytoplasmic (C) fractions, immediately (0 h; lanes 1 and 2) or 1 h (1 h; lanes 3–14) after the injection, and were analyzed using 6% denaturing PAGE.
(D) The same experiments as in (C) were performed in the absence (lanes 1–6) or presence (lanes 7–10) of Rev, except with BSA-NES (190 ng/oocyte; lanes
3, 4, 7 and 8) or BSA-mut (M10) NES, which does not bind CRM1 (190 ng/oocyte; lanes 5, 6, 9 and 10), or without the inhibitor (lanes 1 and 2). RNA
export was analyzed immediately (0 h; lanes 1 and 2) or 1 h (1 h; lanes 3–10) after the injection. (E) Quantitation of the export of spliced ftzRRE RNA
from three independent experiments performed as in (C) and (D). Averages and standard deviations with CTE (gray bars) or BSA-NES (black bars), or
without inhibitors (none; white bars) in the absence (-) or presence (+Rev) of Rev are shown.
Despite the above elegant paradigm, issues regarding the
HIV-1 RNA export still remain and need to be clarified.
For example, if we consider how singly spliced and un-
spliced transcripts are actually exported, the situation is not
at all simple. They should have both the TREX complex
and Rev on the same RNA molecule, and, thus, have the
possibility of utilizing either the TAP-dependent or CRM1-
dependent export pathway, or both. This issue is impor-
tant since accumulating evidence has shown that the export
pathway often influences the nuclear/cytoplasmic fate of a
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given RNA (24–31). Therefore, the two different pathways
for transcripts could have an unfavorable effect on HIV-1




For the pre-ftzRRE plasmid, the RRE260 fragment from
pBS-RRE260 (32) was cloned into the SmaI site of pGEM-
preftz (33). For the intronless ftzRRE plasmid, the intron
was removed by polymerase chain reaction (PCR) from the
pre-ftzRRE plasmid. U6RRE was constructed essentially
as described (34). For pre-CDCRRE and pre-betaRRE,
the RRE260 fragment was inserted into the KpnI site of
pSP14-15 (35) and the BamHI-EcoRI sites of pSP64-H6
(36), respectively. For RRE260 and ERR350, pBS-RRE260
and pBS-ERR350 (a PCR-fragment of 350 nt RRE was
cloned into the HindIII-EcoRI sites of pBS) were linearized
by EcoRI and HindIII, respectively, and transcribed by
T7 RNA polymerase. For pGEX-6P-1-T7-Rev, a PCR-
fragment containing the full-length Rev was cloned into the
EcoRI-XhoI sites of pGEX-6P-1 and annealed oligoDNAs
corresponding to the T7-tag sequence were subsequently
inserted into the EcoRI site. pGEX-6P-1-T7-RevM10 was
constructed by site-directed mutagenesis of pGEX-6P-1-
T7-Rev.
Recombinant proteins
GST-T7-Rev or GST-T7-RevM10 was expressed from
Escherichia coli BL21 (DE3) Codon Plus RIL (Strata-
gene) harboring pGEX-6P-1-T7-Rev or pGEX-6P-1-T7-
RevM10, respectively, by the standard procedure, and the
expressed protein in the bacterial lysate was bound to Glu-
tathione Sepharose beads (GE Healthcare). The bound
beads were washed three times with Buffer 1 (50 mM Tris-
HCl [pH 7.5], 0.5 M NaCl, 1 mM EDTA, 1 mM DTT and
8% glycerol), and were subsequently treated with PreScis-
sion Protease (GEHealthcare; 2U/l in Buffer 1) at 4◦C for
4 days. Themixturewas spun down and the supernatant was
recovered as a purified fraction. FLAG-UAP56 and GST-
Aly/REF (37), GST-hnRNP A1 (27), and CBC (38) were
purified as previously described.
In vitro transcription
32P-labeled RNAs were transcribed as described previously
(39), except that only [-32P] UTP was used. The transcrip-
tion reaction was commonly performed at 37◦C for 45–60
min.
RNA microinjection into Xenopus oocytes
RNA microinjection into Xenopus oocytes was performed
as previously described (39,40). To prepare BSA-NES and
BSA-mut, the PKI NES peptide (CELALKLAGLDIN) or
a mutant peptide (CELALKAAGADIN) was conjugated
to BSA as described previously (19). Analysis and quanti-
tation of RNA bands were performed with BAS-2500 (Fu-
jifilm) and Image Gauge Version 3.45 (Fujifilm).
RNA immunoprecipitation
RNA immunoprecipitation (IP) was performed as de-
scribed previously (40,41). Briefly, the nuclear fraction was
mixed with the indicated antibodies that had been pre-
bound to Protein A-Sepharose beads (GE Healthcare),
equilibrated with RSB100N buffer (10 mM Tris-HCl [pH
7.5], 100 mM NaCl, 2.5 mM MgCl2 and 0.1% Nonidet
P-40), and rotated at 4◦C for 1 h. After the beads were
washed five times with RSB100N buffer, they were in-
cubated in Homomix (50 mM Tris-HCl [pH7.5], 5 mM
EDTA, 1.5% SDS, 300mMNaCl and 1.5mg/ml proteinase
K; Nacalai Tesque) for 30 min at 50◦C. RNA was recov-
ered from the supernatants by phenol/chloroform extrac-
tion and ethanol precipitation, and analyzed by denatur-
ing PAGE and autoradiography. IP using RNase-digested
singly labeled RNA samples was performed as described
(42), except that pre-ftz RRE and intronless ftzRRE RNAs
were used.
In vitro RNA-Rev binding assay
32P-labeled RNAs were mixed with purified recombinant
T7-Rev in the presence of yeast tRNA (1 mg/ml) and in
the presence or absence of CBC, and incubated at 30◦C for
30 min. Then RNA IP was performed as above.
GST-TAP231 pull-down and RNase H digestion/protection
assay
GST-TAP231 pull-down and RNase H
digestion/protection assay were performed as described
previously (42,43). DNA oligos were as follows: A 5′-
AGAGAGGTGGGC-3′, B 5′-CGATGTGCGACC-3′, C
5′-CTTGATCTGCCT-3′, D 5′-CCTGTACCGTCA-3′, E
5′-AATCGCCGGCTC-3′.
Analysis of the composition of EJC
Pre-ftzRRE RNA, singly labeled near the exon–exon junc-
tion, was generated (42) and the splicing reaction was per-
formedwith this substrate in the absence or presence of Rev.
The reaction mixture was treated with a mixture of RNase
A and RNase T1. A short labeled RNA fragment corre-
sponding to the exon–exon junction was protected due to
exon junction complex (EJC) formation. To obtain infor-
mation on the composition of EJC, IP was performed with
the RNase-digested sample.
Transfection
HEK293T cells were maintained under an atmosphere con-
taining 5% CO2 in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, 100 unit/ml
penicillin and 100 g/ml streptomycin. pNL4-3Rev (a
kind gift from Drs M. Matsuoka and E. Kodama), pCI-
FLAG-Rev (44), or pcDNA5-FLAG-TAP (27), pcDNA5-
FLAG-p15 and pcDNA3-GFP (45) were transfected with
polyethyleneimine into 70% confluent HEK293T cells in a
6-well plate. After 24 h, the cells were harvested and washed
with phosphate buffered saline (PBS). The cell pellets were
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used for RNA and protein analyses. The culture super-
natants (2 ml of culture equivalent) were filtrated through
0.45 m filters. Samples were immunoprecipitated with
anti-HIV-1 p55 antiserum raised in rabbits (Bio Academia),
and the IPed proteins were subjected to western blotting
using a murine anti-HIV-1 p24 monoclonal antibody (Ab-
cam).
Semi-quantitative RT-PCR
Total RNA was prepared from culture cells with Sepasol-
RNA I Super (Nacalai Tesque) according to the manufac-
turer’s instructions. RNAs were subsequently treated with
RNase-free DNase (RQ1; Promega) according to the man-
ufacturer’s manual. First-strand cDNA was synthesized
using reverse transcription (SuperScript III First-Strand
Synthesis System; Life Technologies) with a random hex-
amer, and amplified by PCR using an appropriate set of
primers. PCR products were separated by 2% agarose gel
electrophoresis and stained with SYBR Gold (Life Tech-
nologies). Images were obtained with an imaging analyzer
(Typhoon;GEhealthcare). Primers for PCRwere as follows
(46):
unspliced transcript forward 5′-TTCTTCAGAGCAGACC
AGAGCC-3′,
unspliced transcript reverse 5′-CGCTGCCAAAGAGT
GATCTGAG-3′,
singly spliced transcript forward 5′-GCGGCGACTG GA
AGAAGC-3′,
singly spliced transcript reverse 5′-CTCATTGCCACTGT
CTTCTGCTC-3′,
fully spliced transcript forward 5′-GCGGCGACTGAATT
GGGTGT-3′,
fully spliced transcript reverse 5′-GATTGGGAGGTGGG
T TGCTTTG-3′,
GFP mRNA forward 5′-AACCACTACCTGAGCACC
CAG-3′,
GFP mRNA reverse 5′-CACCACACTGGACTAGTGGA
TC-3′.
GST pull-down
Purified recombinant CBP80 (3 g) was incubated with
either GST, GST-T7-Rev, GST-Aly/REF or GST-hnRNP
A1 (1 g) in the presence of 1 mg/ml RNase A and in the
presence or absence of T7-Rev (0, 2.5, 7.5, 25 g) in 20 l
D’K100 buffer (20mMHepes-KOH [pH 7.9], 100mMKCl,
0.2 mM EDTA, 1 mM DTT and 10% glycerol) at 30◦C for
30 min. The reaction mixture was rotated with Glutathione
Sepharose beads in 100 l RSB100N at 4◦C for 1 h. After
washing five times with RSB100N, the bound material was
recovered and analyzed by SDS-PAGE/western blotting.
RESULTS
Recapitulation of the export of the singly spliced HIV-1 tran-
script in Xenopus oocytes
Elucidating the framework of Rev function was greatly
aided by experiments using the heterologous Xenopus
oocyte microinjection system, in which RNA export can
be separated from other steps of gene expression, making
it possible to clearly demonstrate the function of Rev in
RNA export (19,34,47,48). To understand the nuclear ex-
port of HIV-1 transcripts, we first sought to reconstruct the
export of singly spliced transcripts in the well-established
Xenopus oocytemicroinjection system, and generated an ar-
tificial RNA substrate, pre-ftzRRE, schematically shown in
Figure 1B. The RRE sequence fromHIV-1 was fused to the
Drosophila fushitarazu (ftz) gene containing an intron, one
of the most conventional splicing substrates used in Xeno-
pus oocytes and mammalian cells (29,49). The spliced prod-
uct of pre-ftzRRERNAmay have both the TREX complex
andRev on the sameRNA in cases in which the Rev protein
was supplied (Figure 1B). By which pathway this spliced
RNA was exported was examined in the Xenopus oocyte
microinjection experiments.
After 1 h incubation, pre-ftzRRE RNA had been effi-
ciently spliced, and a fraction of spliced ftzRRE RNA had
been exported to the cytoplasm, while the excised intron
stayed in the nucleus (Figure 1C, lanes 3 and 4). Elon-
gated U1-ftz RNA (elongated U1 RNA), which was pre-
viously shown to behave like an mRNA in nuclear export
(29,41), was also partially exported, whereas U6RRE (34)
and U6ss RNAs mostly or completely stayed in the nu-
cleus, respectively (Figure 1C, lanes 3 and 4). When the
same RNA mixture was injected with the purified recom-
binant Rev protein, the export of U6RRE was greatly stim-
ulated, as expected (34), while export of the elongated U1
was hardly affected. The export of spliced ftzRRE RNA
was slightly stimulated (Figure 1C, lanes 9 and 10, and E
for quantitation).
Two inhibitors of RNA export were employed to exam-
ine the export pathway of spliced ftzRRE in the absence
or presence of the Rev protein. The first was constitutive
transport element (CTE) RNA from type D retroviruses,
which was shown to specifically bind to TAP and thereby
inhibit mRNA export when a saturating amount was in-
jected (50,51). The second was a conjugate of NES peptides
coupled to BSA (BSA-NES), which was shown to saturate
CRM1-dependent export (19).
When a saturating amount of CTE was injected together
with RNAs in the absence of the Rev protein, the export
of spliced ftzRRE RNA and elongated U1 RNA was in-
hibited as expected, which indicated that these RNAs uti-
lized the mRNA pathway (Figure 1C, lanes 5 and 6, and
E). When BSA-NES was injected in the absence of Rev, the
export of spliced ftzRRE RNA and elongated U1 RNA
was consistently unaffected (Figure 1D, lanes 3 and 4,
and E). In contrast, in the presence of Rev, the export of
U6RRE was not affected by CTE (Figure 1C, lanes 11 and
12), but was severely inhibited by BSA-NES (Figure 1D,
lanes 7 and 8), indicating that U6RRE utilized the CRM1-
dependent pathway in the presence of Rev. Most impor-
tantly, the export of spliced ftzRRE RNA was also un-
affected by CTE (Figure 1C, lanes 11 and 12), but was
strongly inhibited by BSA-NES (Figure 1D, lanes 7 and
8), which indicated that the majority of spliced ftzRRE
RNA was exported via the CRM1-dependent pathway in
the presence of Rev. These results clearly indicated that the
export of spliced ftzRRE RNA almost exclusively utilized
the CRM1-dependent pathway in the presence of Rev. Since
 at Library of Research Reactor Institute, K
yoto U






Nucleic Acids Research, 2014, Vol. 42, No. 10 6649
the accumulation in the cytoplasm of the singly spliced tran-
script was shown to be dependent on Rev activity in HIV-
1-infected cells (52,53), it is very likely that the above model
system in Xenopus oocytes recapitulated the export of the
singly spliced HIV-1 transcript.
HIV-1 Rev not only induces CRM1-dependent export, but
also inhibits TAP-dependent export of RRE-containing
spliced RNAs
The export pathway of spliced ftzRRE RNA was almost
completely shifted from the TAP-dependent mRNA path-
way to the CRM1-dependent pathway by the presence of
Rev. One might think that RNA could be exported by
the TAP-dependent pathway similar to elongated U1 RNA
in the presence of both Rev and BSA-NES; however, the
export of RNA was actually inhibited (Figure 1E, black
bar). This strongly suggested that the Rev protein prevented
spliced ftzRRERNA from utilizing the TAP-dependent ex-
port pathway. To confirm this, we next examined the effect
of the Rev M10 mutant on RNA export (Figure 2). Since
M10 has a mutation in the NES, it is unable to interact
with CRM1 (20,54). If the Rev M10 mutant also inhibits
the TAP-dependent export of spliced ftzRRE RNA, the in-
hibitory activity of Rev can be clearly separated from its ac-
tivity to induce CRM1-dependent export.
Co-injection of the wild-type Rev protein had the same
effect as described above. However, co-injection of the same
amount of theM10 proteinmarkedly inhibited the export of
spliced ftzRRERNArelative to that with the buffer control,
whereas export of the other RNAs was unaffected (Figure
2A, lanes 3, 4, 7 and 8, and B for quantitation). When we
employed pre-ftzERR RNA, in which the RRE sequence
was fused to ftz pre-mRNA in the antisense orientation, the
M10 protein had no effect (Supplementary Figure S1A and
B). Moreover, when we employed pre-CDCRRE and pre-
betaRRE, in which RRE was fused to chicken -crystallin
pre-mRNA (35) and human -globin pre-mRNA (36), re-
spectively, the M10 protein also specifically inhibited ex-
port of the corresponding spliced RNAs (Figure 2C and
D, and Supplementary Figure S1C and D). These results,
taken together, clearly indicated that the Rev protein pre-
vented RRE-containing spliced RNAs from utilizing the
TAP-dependent export pathway.
Rev inhibits the association of TAPwith spliced ftzRRERNA
Since the Rev protein suppressed TAP-dependent export
of spliced RRE-containing RNAs, we next investigated
whether the association of the mRNA export factor TAP
with RNAs was affected by Rev. To this end, we performed
GST-TAP231 pull-down experiments (43).
Both spliced ftzRRE and elongated U1 RNAs were
specifically precipitated by GST-TAP231, as expected, in
the absence of Rev, which indicated that these two RNAs
were in a state that was capable of TAP association in the
nucleus (Figure 3A, lane 3). In contrast, in the presence of
Rev, the association ability was reduced by 70%with spliced
ftzRRE RNA, but not with elongated U1 in this condi-
tion (Figure 3A, lane 4, and Supplementary Figure S2A for
RNA binding of Rev). These results indicated that the Rev
protein can specifically inhibit the association of TAP with
spliced ftzRRE RNA.
Rev inhibits the association of TREX components with
spliced ftzRRE RNA
To understand how Rev inhibited the association of TAP
with spliced RRE-containing RNAs, we next examined the
effect of Rev on the association of Aly/REF with RNA.
RNA IP experiments were performed either from the nu-
clear fraction of oocytes that had been injected with the
same 32P-labeled RNAs as in Figure 3A (Figure 3B and C,
and Supplementary Figure S2B) or from the in vitro splicing
reaction mixture (Supplementary Figure S2C–E).
mRNA-specific binding proteins such as Aly/REF, Y14
and the bulk SR proteins were associated with spliced
ftzRRE RNA and elongated U1 RNA in the oocytes (Fig-
ure 3B, lanes 3 and 5, and Supplementary Figure S2B),
and co-injection of Rev only reduced the association of
Aly/REF with spliced ftzRRE RNA (by 54%; Figure 3B,
lanes 4 and 6, and Supplementary Figure S2B). Further-
more, antibodies against Aly/REF specifically precipitated
spliced ftzRRERNA from the in vitro splicing reactionwith
HeLa cell nuclear extracts, and adding the Rev protein to
the reaction greatly reduced the association ofAly/REF (by
50% for 11G5 and by 75% for KJ58 (10); Supplementary
Figure S2C–E). The association of Y14 was not affected by
Rev (Supplementary Figure S2E).
UAP56 is another component of the TREX complex
(3) and promotes the recruitment of Aly/REF onto both
spliced and intronless mRNAs through their direct interac-
tion (37,55,56). Co-injection of Rev reduced the association
of FLAG-UAP56 and Aly/REFwith spliced ftzRRERNA
but not spliced ftz RNA (by 50%; Figure 3C). These results
clearly indicated that Rev specifically inhibited the associa-
tion of Aly/REF and UAP56, possibly in the context of the
TREX complex, with spliced ftzRRE RNA (Figure 3D).
Rev does not interfere with EJC formation
The splicing reaction deposits another large protein com-
plex, the EJC, onto mRNAs, a component of which is Y14
(42,57). Because Rev did not inhibit the association of Y14
(Figure 3B and Supplementary Figure S2E), it was likely
that Rev did not inhibit the formation of EJC on spliced
ftzRRE RNA. To confirm this, we employed the RNase H
protection assay originally used to map the location of EJC
on spliced RNA (42). The presence of EJC should inhibit
cleavage by RNase H with an antisense DNA oligo that hy-
bridizes near the exon–exon junction. In the absence of Rev
(Figure 4A), spliced ftzRRE RNA was efficiently cleaved
by RNase H with various oligo DNAs, which hybridized to
various regions of the splicedRNA, except with oligo B that
hybridized near the exon–exon junction, confirming that
EJCwas properly formed near the exon–exon junction (Fig-
ure 4A, left), whereas control intronless ftzRRE RNA was
cleaved with all the oligos (Figure 4A, right). Importantly,
exactly the same results were obtained even in the presence
of Rev (Figure 4B), which indicated that Rev did not af-
fect the formation of EJC itself on spliced ftzRRE RNA.
And the composition of EJC was not altered by Rev since
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Figure 2. Inhibition of TAP-dependent RNA export by Rev. (A) The same 32P-labeled RNAmixture as in Figure 1 together with 32P-labeled m7G-capped
U5Sm RNA was microinjected into the nucleus of oocytes. The effect of the wild-type Rev or Rev M10 mutant protein (160 fmol/oocyte) was examined
as in Figure 1. (B) Quantitation of the export of spliced ftzRRE, elongated U1 and U5 RNAs from three independent experiments performed as in (A).
Averages and standard deviations withM10 (black bars) or without proteins (buffer; white bars) are shown. (C andD) The same 32P-labeled RNAmixture
as in (A), except that either pre-CDCRRE (C) or pre-betaRRE (D) was used instead of pre-ftzRRE, was microinjected into the nucleus. The effect of the
wild-type Rev or Rev M10 mutant protein (160 fmol/oocyte) was examined as in (A). See also Supplementary Figure S1 for quantitation.
the incorporation of Aly/REF as well as Y14 into EJC was
not hindered by Rev (Supplementary Figure S3). It should
be emphasized that the association of the TREX complex
with RNA appears to be more important for RNA export
(4,58).
Rev inhibits the association of Aly/REFwith intronless RRE-
containing RNAs
Since TAP and Aly/REF were also shown to be involved in
the nuclear export of intronless mRNA (10,29,37,41,58,59),
whether Rev could inhibit the association of Aly/REF with
intronless mRNAs containing RRE was next examined
(Figure 5). TAP-dependent export of intronless ftzRRE
RNA was markedly suppressed by Rev, whereas TAP-
dependent export of elongated U1 was hardly affected (Fig-
ure 5C for quantitation). This suppression of the TAP-
dependent export pathway was likely due to the reduced as-
sociation of Aly/REF with intronless ftzRRE RNA in the
presence of Rev (Figure 5D and Supplementary Figure S2A
for RNA binding of Rev). These results confirmed that Rev
generally inhibited the association of Aly/REF with RRE-
containing RNAs regardless of whether RNAs had been
produced through splicing or not (Figures 3D and 5E). It
is likely that this mechanism operates during the export of
the unspliced HIV-1 transcript.
The TAP-dependent pathway reduces singly spliced and un-
spliced HIV-1 RNA levels
Why the TAP-dependent pathway had to be suppressed for
singly spliced and unspliced transcripts by Rev remained
unclear. To obtain a clue, we investigated what happened
to HIV-1 gene expression when TAP was artificially overex-
pressed (Figure 6).
TheHIV-1DNA clone pNL4-3 derivative, pNL4-3Rev,
was used for HIV-1 gene expression. pNL4-3Rev has a
mutation (ATG to ACG) in the start codon of the Rev gene
in pNL4-3, which is a silentmutation for theHIV-1 Tat gene
(Figure 6A). pCMV-Rev was transfected into HEK293T
cells concurrently with pNL4-3Rev to supply the Rev pro-
tein. The Rev protein was required for the expression of
a translation product of the unspliced transcript, Gagp24
(Figure 6B and Supplementary Figure S4B), which demon-
strated that this virus expression system worked well.
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Figure 3. Effect of Rev on the association of mRNA binding proteins. (A) The same 32P-labeled RNAmixture as in Figure 1 was injected into the nucleus
in the absence or presence of Rev. The nuclear fraction was prepared after 1 h, and GST pull-down was performed with glutathione beads that had been
pre-bound with either the GST-TAP231 or GST protein. RNA precipitated with each type of bead was recovered and analyzed. The input lanes were
loaded with 10% of each input mixture. (B) The nuclear fraction was prepared as in (A), and IP was performed with the anti-Aly/REF monoclonal
antibody (11G5, Aly), anti-Y14 monoclonal antibody (4C4, Y14) or anti-Myc monoclonal antibody (9E10, Myc) that had been pre-bound to Protein
A-Sepharose beads. RNA precipitated with each antibody was recovered and analyzed. (C) The recombinant FLAG-UAP56 protein (50 fmol/oocyte) was
pre-injected into the cytoplasm. After 16 h incubation, a second microinjection was performed into the nucleus with the same 32P-labeled RNA mixture
as in Figure 1, except that pre-ftz RNA was used instead of elongated U1 RNA, in the absence or presence of Rev. IP was performed with 11G5, the
anti-FLAG monoclonal antibody (M2, FLAG), or 9E10. (D) Rev inhibits the association of TAP and the TREX complex with spliced ftzRRE RNA.
To examine the effect of TAP on virus expression,
pNL4-3Rev was transfected with pCMV-Rev, pCMV-
TAP, pCMV-p15 and pCMV-GFP as a control. When the
TAP-p15 heterodimer was overexpressed by six times that
of endogenous TAP (Supplementary Figure S4C), the level
of singly spliced (4-kb, Env mRNA) and unspliced (9-kb)
transcripts was significantly reduced, whereas that of the
fully spliced (2-kb, Tat mRNA) transcript was not (Fig-
ure 6C, lanes 1 and 2, and D for quantitation), suggest-
ing that an enhanced association of TAP to the intron-
containing HIV-1 transcripts somehow reduced their ex-
pression levels. If Rev inhibits the association of TAP with
RRE-containing RNAs in HEK293T cells, reduced RNA
levels due to TAP-p15 overexpression may possibly be re-
covered by Rev overexpression. Rev co-overexpressed with
TAP-p15 (Supplementary Figure S4C) indeed canceled this
reduction (Figure 6C, lanes 1, 2 and 4, and D), which sup-
ported the model in which Rev inhibits the association of
TAP with singly spliced and unspliced transcripts in HIV-
1-expressing cells. However, Rev overexpression alone did
not affect the levels of singly spliced and unspliced tran-
scripts, but reduced the fully spliced transcript. The reason
for the reduced levels of the fully spliced transcript is un-
known. The reduction is likely unrelated to the splicing re-
action because TAP-p15 overexpression reduced the tran-
scripts in the presence of the splicing inhibitor, Spliceostatin
A (SSA) (Supplementary Figure S4D) (60). Consistent with
the level of the unspliced transcript, TAP-p15 overexpres-
sion reduced the cellular level of Gagp55, translated from
the transcript, and Gagp24, processed fromGagp55, and Rev
co-overexpression canceled this reduction (Figure 6E). Vi-
ral production was also likely suppressed by TAP-p15 over-
expression, as demonstrated by the amounts of Gagp24 in
the culture media (Figure 6F) (25). These results are consis-
tent with the hypothesis that Rev suppresses the TAP path-
way to avoid a reduction in the expression of singly spliced
and unspliced transcripts that leads to reduced viral propa-
gation.
We tried to investigate whether Rev inhibits the associ-
ation of TAP with singly spliced and unspliced transcripts
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Figure 4. Effect of Rev on EJC formation. 32P-labeled pre-ftzRRE RNA
(left) or intronless ftzRRERNA (right) was microinjected into the nucleus
in either the absence (A) or presence (B) of Rev. The nuclear fraction was
prepared after 1 h, and RNase H digestion was performed with the anti-
sense oligoDNAsA–D.RNAdigestion was analyzed using 6% denaturing
PAGE.
in HIV-1-expressing cells. However, we could not detect the
association of TAP with the transcripts, regardless the Rev
expression. This may be because TAP association destabi-
lizes the transcripts.
Molecular mechanism for Rev’s remodeling of the composi-
tion of export RNPs
The above results show that Rev generally inhibits the asso-
ciation of the TREX complex with RRE-containing RNAs.
However, the detailed mechanism for this was still un-
known. RRE is located in the second intron of the HIV-1
primary transcript, while the TREX complex is recruited to
a region near the 5′-terminus of mRNA because Aly/REF
interacts with CBC. How distantly positioned Rev affected
the association of the TREX complex remained to be elu-
cidated. We speculated that Rev bound to RRE may inter-
act with CBC bound to the cap of the same RNA, thereby
competitively inhibiting the interaction between CBC and
Aly/REF.
To investigate Rev’s association with the cap-proximal re-
gion, we performed RNA IP experiments from the nuclear
fraction ofXenopus oocytes (Figure 7A). The nuclear lysate
was prepared 1 h after the injection and was incubated with
an antisense oligo E that hybridized with spliced ftzRRE
as shown in Figure 7A, located between oligos A and B in
Figure 4. This triggered digestion by endogenous RNase
H to produce 5′ and 3′ fragments (Figure 7A, lanes 5–8).
When purified recombinant T7-Rev protein was injected
with RNAs, not only spliced ftzRRE RNA and the 3′ frag-
ment, but also the 5′ fragment were precipitated by the anti-
T7 antibody (Figure 7A, lanes 9 and 10). In contrast, no
fragment was precipitated when control pre-ftzERR RNA
was injected (Figure 7A, lanes 11 and 12). These results in-
dicated that Rev bound to not only the RRE sequence, but
also directly or indirectly to the region near the 5′-terminal
cap structure of RRE-containing RNA.
How can Rev effectively associate with the cap-proximal
region?We suspected an interaction between Rev and CBC.
GST-Rev, but neither GST nor GST-hnRNP A1, pulled
down CBP80, a component of CBC, in the presence of
RNase A (Figure 7B, lane 6), which suggested that Rev
directly interacted with CBC. The direct interaction be-
tween Aly/REF and CBP80 was verified (Figure 7B, lane 7)
(4,5). Furthermore, we found that the interaction between
CBP80 and Aly/REF decreased with the addition of Rev in
a dose-dependent manner (Figure 7C), indicating that Rev
competitively inhibited the interaction between CBC and
Aly/REF. Although RNA was not present in this in vitro
system, Rev should interact with CBC most effectively on
the same RNA molecule in vivo. Recombinant CBC indeed
stimulated the association of Rev with m7G-capped RRE
RNA in vitro (Figure 7D). This stabilization of Rev’s RRE-
binding by CBC should contribute to the efficient interac-
tion between Rev bound to RRE and CBC bound to the
cap, which may be mediated by RNA’s looping-out or Rev’s
multimerization on the entire RNA region (Figure 8, see the
Discussion section). This model can also explain how Rev’s
inhibition is specific only toRNAs containingRRE, but not
to RNAs without the element.
DISCUSSION
Model for Rev’s suppression of the TAP-dependent pathway
Our model for the role of the HIV-1 Rev protein in sup-
pressing TAP-dependent export of RRE-containing RNAs
is shown in Figure 8. Once a sufficient amount of the Rev
protein accumulated in the nucleus, Rev bound to RRE of
singly spliced and unspliced transcripts. Rev interacted with
CBC at the 5′-terminus ofRNA (Figure 7). Howwas this in-
teraction achieved? One possibility is that RRE-containing
RNA may form a closed-loop RNP by a physical associa-
tion between the 5′-terminus and RRE through the CBC–
Rev interaction (Figure 8 middle), similar to that between
the 5′-terminal and poly(A) tail in mRNA translation (61).
Alternatively, Rev may multimerize on the entire region of
RNA, not only on the RRE region as previously demon-
strated (16) (Figure 8 right). This multimerization may be
stimulated by CRM1-binding because it enhances the Rev–
Rev interaction (62). CBC stabilized the association of Rev
with the 5′ region of the transcripts (Figure 7D). This stabi-
lization may enhance the multimerization of Rev. However,
the fact that RNA is cleavable by DNA oligos and RNase
H may favor the former model (Figures 4 and 7). In any
case, the interaction between CBC and Rev inhibited the
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Figure 5. Effect of Rev on the export of intronless RNA containing RRE. (A and B) The same experiments as in Figure 1C and D, respectively, were
performed, except that intronless ftzRRE RNA was used instead of pre-ftzRRE RNA and incubation was performed for 1.5 h. (C) Quantitation of the
export of ftzRRE RNA in (A) and (B). (D) IP was performed as in Figure 3B, except that intronless ftzRRE RNA was used instead of pre-ftzRRE RNA.
(E) Rev inhibits the association of TAP and the TREX complex with intronless ftzRRE RNA.
association of Aly/REF to the region near the 5′-termini of
the transcripts through competitive inhibition of the inter-
action between CBC and Aly/REF (Figure 7C). Accord-
ingly, the TAP-dependent pathway was inhibited and the
CRM1-dependent pathway was induced.
Although our results shown here support the above
model, additional mechanisms may be involved in this re-
modeling. Many RNA helicases have been reported to in-
teract with Rev. Such RNA helicases, in cooperation with
Rev, may actively remove Aly/REF from RNA. RNA he-
licase DDX3, which was shown to be important for HIV-1
RNA export (63), may be a good candidate. In addition to
Aly/REF, some shuttling SR proteins are thought to func-
tion as redundant adaptors for TAP recruitment (43,64). In
this regard, although the association of bulk SR proteins
was not affected by the presence of Rev (Supplementary
Figure S2B), the possibility that the association of some
specific SR proteins may be hindered by Rev cannot be ex-
cluded.
Biological significance for Rev’s suppression of the TAP-
dependent pathway
An important question is why it is necessary for HIV-1
to suppress the TAP-dependent RNA export pathway of
singly spliced and unspliced transcripts. In this regard, we
showed that TAP-p15 overexpression, which may lead to
the enhanced association of TAP with RNA, specifically re-
duced the level of singly spliced and unspliced transcripts
(Figure 6C and D). Thus, HIV-1 inhibited the association
of TAP with RRE-containing RNAs by utilizing Rev, most
likely in order to circumvent the TAP-mediated reduction
in HIV-1 gene expression.
This finding raises a new question that needs to be solved:
what is the mechanism of the TAP-mediated reduction of
singly spliced and unspliced transcripts? One possible ex-
planation is based on the feature that transcripts contain
introns. TAP being associated with unspliced pre-mRNAs
is unfavorable because TAP may aberrantly export pre-
mRNAs to the cytoplasm, which may lead to their transla-
tion into harmful proteins. To prevent this, the cell may ac-
tively retain and splice pre-mRNAs that are bound by TAP.
In this regard, CTE-containing, therefore TAP-bound, pre-
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Figure 6. Effect of TAP-p15 overexpression on HIV-1 expression. (A) Genome organization of HIV-1 NL4-3Rev. The start codon of the Rev gene was
mutated from ATG to ACG. (B) HEK293T cells in a 6-well plate (70% confluent) were transfected with pcDNA3-GFP (1 g), pNL4-3Rev (1 g), and
either pCI-neo (0.1 g) (−) or pCI-FLAG-Rev (0.1 g) (+). After 24 h, cells were collected and proteins from cell pellets were analyzed by SDS-PAGE and
western blotting with rabbit anti-Gagp55 antiserum. UT: untransfected cells were used as a control. (C) HEK293T cells in a 6-well plate (70% confluent)
were transfected with pcDNA3-GFP (1 g), pNL4-3Rev (1 g), pCI-FLAG-Rev (0.1 or 1 g), and either pcDNA5 (1 g) (−) or pcDNA5-FLAG-TAP
(0.6 g) plus pcDNA5-FLAG-p15 (0.3 g) (+). 0.9 g of pCI-neo was added for 0.1 g of pCI-FLAG-Rev to equalize the amount of plasmid DNAs.
Supernatants and cells were collected after 24 h. RNA from cell pellets was subjected to semi-quantitative RT-PCR. PCR products were analyzed by
electrophoresis in a 2% agarose gel. (D) Quantitation of the relative level of RNAs from three independent experiments performed as in (C). GFP mRNA
was used for normalization. 0.1 g of the pCI-FLAG-Rev sample (lane 1) was set to 1. Averages and standard deviations are shown. (E) Protein from the
cell pellets in (C) was analyzed by SDS-PAGE and western blotting with rabbit anti-Gagp55 antiserum or the anti-GFP antibody. UT: untransfected cells
were used as a control. U2AF65 was a loading control. (F) The filtrated media from (C) were immunoprecipitated with rabbit anti-Gagp55 antiserum and
detected by western blotting with the monoclonal anti-Gagp24 antibody.
mRNAs were shown to be retained in the nucleus and re-
duced by the NPC-associated protein TPR (24).
Relationships to other viral systems
Human T-lymphotropic virus (HTLV) also belongs to a
retrovirus family and utilizes the homologous mechanism
to export viral RNAs by the Rex-RxRE system (Rev-RRE
in HIV-1). It is interesting to determine whether Rex has
the same activity as theHIV-1Rev protein to suppress TAP-
dependent export of viral RNAs.Herewe found thatRex in-
teracted directly or indirectly with CBP80 (Supplementary
Figure S5). Targeting Rev/Rex’s remodeling activity could
introduce a novel useful anti-retroviral therapy for HIV and
HTLV. Other viruses also take advantage of RNA export
regulation for their gene expression (65). The Herpes Sim-
plex Virus ICP27 protein interacts with Aly/REF and re-
cruits it onto intronless viral mRNAs that are otherwise in-
efficient substrates for Aly/REF association, which induces
TAP-dependent export of viral mRNAs. The Epstein–Barr
virus EB2 protein also has very similar activity. These two
viral proteins are the exact mirror images of the function of
theHIV-1 Rev protein, which inhibits Aly/REF association
with RNA. Therefore, it may be a commonly used strategy
for viruses to control the recruitment of Aly/REF in order
to regulate export of their own mRNAs.
One RNA-one export pathway hypothesis
A plethora of evidence has already been obtained sup-
porting the link between the RNA export pathway and
nuclear/cytoplasmic fate of RNA (24–31). Therefore, more
than oneRNAexport pathway for a singleRNAmolecule is
thought to be problematic for export RNPs. One of the so-
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Figure 7. Molecular mechanism of remodeling of export RNPs by Rev. (A) 32P-labeled U6ss RNA together with either pre-ftzRRE RNA (RRE) or
pre-ftzERR RNA (ERR) was microinjected into the nucleus in either the absence or presence of Rev. The nuclear fraction was prepared after 1 h (lanes
1–4), and RNase H digestion was performed with the antisense oligo DNA E (lanes 5–8). The reaction mixture was immunoprecipitated with the anti-T7
antibody (lanes 9–12). RNAs were analyzed using 6% denaturing PAGE. (B) Purified recombinant CBP80 (3 g) was pulled down by GST, GST-T7-Rev,
GST-Aly or GST-hnRNPA1 (GST-A1) (1 g each) in the presence of RNase A (1 mg/ml). Pulled down CBP80 was separated by SDS-PAGE and detected
by western blotting. (C) Recombinant CBP80 (3 g) was pulled down by GST or GST-Aly (1 g each) in the presence of RNase A (1 mg/ml) and in the
absence or presence of T7-Rev (0.2, 1, 5 or 25 g), and was analyzed as in (B). (D) 32P-labeled U6ss, m7G-capped 350 nt-ERR RNA and m7G-capped
260 nt-RRERNAwere incubated with or without recombinant T7-Rev (30 nM) or CBC (30, 100, 300 nM). The reaction mixture was immunoprecipitated
with the anti-T7 antibody. Precipitated RNAs were analyzed by 8% denaturing PAGE.
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Figure 8. A model of how the HIV-1 Rev protein remodels viral export RNPs. Not all RNA binding proteins are shown for the sake of clarity. See the
Discussion section for details.
lutions is the mechanism that allows the recruitment of ex-
port factors for only one particular export pathway.We pre-
viously observed a similar RNP remodeling process prior
to the export of cellular RNAs (29,41). If an RNA is com-
mitted to the mRNA export pathway, U snRNA-specific
export factors such as PHAX, an adaptor between CBC
and CRM1 (38), are not found on the RNA. Conversely,
if an RNA is committed to the U snRNA export pathway,
mRNA-specific export factors such as Aly/REF are not
found on theRNA. Thus, recruitingmRNA-specific factors
andU snRNA-specific factors is mutually exclusive (29,41).
This RNP remodeling is achieved by a similar mechanism
to that described here for HIV-1 transcripts (27). The nu-
clear RNA binding protein hnRNP C binds to mRNA and
CBC. Therefore, the association of PHAX with mRNA is
competitively inhibited. Interestingly, when PHAXwas per-
mitted to associate with mRNA by hnRNP C knockdown,
the export of mRNA was inhibited (27). This finding also
illustrates that the choice of RNA export pathway defines
the RNA’s fate. It is also worth noting that CBC-bound hn-
RNP C must be replaced by Aly/REF in the course of the
formation of export-competent RNP (27). Specifically for
m7G-capped RNA, CBC binding proteins, such as hnRNP
C, Aly/REF and PHAX, serve as a landmark of the RNA
state. In other words, the identity of the factor that interacts
with cap-bound CBC and occupies the cap-proximal region
determines the RNA export pathway. Owing to this mecha-
nism, if RNA is committed to one pathway, the association
of the export factors of other pathways is competitively pre-
vented. Rev may favor viral gene expression by occupying
the region and determining the RNA export pathway.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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